Our Partners and Clients
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 240 years of distinguished history in Japan.
GATC Health is accelerating, optimizing and de-risking drug discovery and development like never before. GATC Health’s advanced technology platform closes the “AI Gap” to save years of R&D time and potentially hundreds of millions of dollars per project for pharma partners. This breakthrough is possible with GATC Health’s patented AI platform, which functionally acts like a digital humanoid. Drawing on massive sets of public and proprietary data, GATC Health’s AI simulates human biology’s billions of interactions simultaneously for rapid and accurate target discovery, drug identification, development and validation.
SHANDA CONSULT is an international consulting firm based in Nicosia, Cyprus, with a wide network of trusted partners in the European Union, the Mediterranean, the Middle East, and Asia. The company offers an integrated range of business advisory services designed to facilitate and initiate cross-border industrial investments. They support clients with corporate restructuring and performance improvement and facilitate corporate relocation and business localization, including establishing a new representative and branch offices and special purpose vehicles for investments and market entry.
The Yuan is a new tech community platform focused on AI in healthcare, ML, and related disciplines. Their aim is to provide an open forum for global innovators, entrepreneurs, and others in the AI world to exchange insights into this transformational technology. The company is seeking talented AI professionals and social commentators to share their expertise and wisdom to inform our readership of investors, scientists, researchers, engineers, graduate students, policymakers, healthcare providers and patients, and the public at large, of developments in this novel arena that is poised to become central to every of a field of human endeavor.